Shifting Focus: BioXcel Drives Agitation Treatment Market Amid Workforce Changes
BioXcel Therapeutics shifts gears, cutting jobs and focusing on revolutionizing the Agitation Treatment Market. Discover how they’re reshaping healthcare with BXCL501 for schizophrenia, bipolar disorders, and dementia. A game-changer for patient care! #AgitationTreatment #HealthcareInnovation